Howard Levine, PhDNational Leader, BioProcess Technology Group at BDO
Howard L. Levine, Ph.D., is currently the National Leader of the the BioProcess Technology Group, a part of the life sciences practice of BDO USA, LLP, a professional services company. Dr. Levine is a pioneer and thought leader in the biopharmaceutical industry with extensive strategic and operational experience in biopharmaceutical product development and commercialization. In his 40 years in the biopharmaceutical industry Dr. Levine has assisted numerous companies in developing biological products, provided strategic input in the development of new manufacturing technologies, and participated in the successful commercialization of several of these products. In 1994, Howard founded BioProcess Technology Consultants (BPTC), a leading consulting company that provided integrated strategic, technical, and regulatory advice on biopharmaceutical product development to a broad range of companies. He served as President, and CEO of BPTC until its merger with BDO in 2019. Prior to founding BPTC, Dr. Levine was Vice President of Manufacturing Operations at Repligen Corporation and previously held positions of increasing responsibility in process development and manufacturing at Genentech, Amgen, and Xoma.